Bottle of 10 ml.
NazivinÂ® Sensitive (oxymetazoline) has a vasoconstrictor effect. When applied locally to the inflamed mucous membrane of the nasal cavity, it reduces its swelling and discharge from the nose. Restores nasal breathing.
Elimination of edema of the mucous membrane of the nasal cavity helps to restore aeration of the paranasal sinuses of the nasal cavity, middle ear cavity, which reduces the likelihood of bacterial complications (sinusitis, sinusitis, otitis media).
When applied topically at therapeutic concentrations, it does not irritate or cause hyperemia of the nasal mucosa.
oxymethazoline begins to act quickly, in a few minutes Duration of action of NazivinÂ® Sensitive up to 12 hours.
Pharmacokinetics. With topical intranasal use, oxymetazoline does not have a systemic effect.
The half-life of oxymetazoline when administered intranasally is 35 hours. 2.1% of oxymetazoline is excreted in the urine and about 1.1% in the feces.
Colds or viral infections of the upper respiratory tract, accompanied by a runny nose, sinusitis, eustachiitis, otitis media, rhinitis of any etiology
To eliminate edema before diagnostic procedures in the nasal passages.
Hypersensitivity to the drug.
NazivinÂ® Sensitive nasal spray dosage (11.25 mcg / dose) is contraindicated in children under 1 year of age.
Precautions for: increased intraocular pressure
chronic heart failure
arterial hypertension, angina pectoris
chronic renal failure
in patients with prostatic hyperplasia with clinical symptoms (urinary retention) srdlklerkprikter hypertension
Use during pregnancy and lactation
When using during pregnancy or breastfeeding, the recommended dose should not be exceeded.
The drug can be used only if the potential benefit to the mother outweighs the potential risk to the fetus and baby.
1 ml of solution contains:
Oxymethazoline hydrochloride 0.250 mg
citric acid monohydrate 0.609 mg
sodium citrate dihydrate 3.823 mg srdlkggp 85 gldrgp 85 grldgrp 85 gld
Total: 1,008.00 mg, equivalent to 1 ml.
Dosage and Administration
NazivinÂ® Sensitive Nasal Spray Dosage 11.25 mcg / dose is intended for intranasal administration.
For children aged 1 to 6 years: 1 injection of NazivinÂ® Sensitive Nasal Spray, dosed 11.25 mcg / dose in each nostril 2-3 times a day. The drug is used for 5-7 days. The drug can be re-prescribed only after a few days.
Doses higher than recommended may only be used under medical supervision. A single injection with a volume of 45 Î¼l contains 11.25 Î¼g of oxymetazoline hydrochloride – for NazivinÂ® Sensitive Nasal Spray, dosed 11.25 Î¼g / dose.
burning or dry nasal mucosa, sneezing, nosebleeds, Quincke’s edema, pruritus. In rare cases: after the effect of the use of the drug NazivinÂ® Sensitive disappears, a feeling of nasal congestion (reactive hyperemia).
high blood pressure, headache, dizziness, palpitations, tachycardia, anxiety, irritability, sleep disturbance (in children), nausea, insomnia, exanthema, impaired vision (in the eyes).
fatigue, drowsiness, restlessness, hallucinations,
cramps, respiratory arrest (in infants).
Prolonged continuous use of vasoconstrictor drugs can lead to tachyphylaxis, atrophy of the nasal mucosa and recurrent edema of the nasal mucosa (drug rhinitis).
Symptoms (after significant overdose or accidental ingestion):
pupil narrowing, nausea, vomiting, cyanosis, fever, tachycardia, arrhythmia, vascular failure, arterial hypertension, arterial hypertension, arterial hypertension Mental disorders, as well as CNS function depression, accompanied by drowsiness, decreased body temperature, bradycardia, arterial hypotension, respiratory arrest, and possible coma development may occur.
gastric lavage, activated charcoal and urgent medical attention.
Do not store above 30 ° C. Keep out of reach of children.
Terms and conditions
Ursafarm Arzneimittel, Germany